312 related articles for article (PubMed ID: 30289976)
1. Proteomics of neurodegenerative diseases: analysis of human post-mortem brain.
Li KW; Ganz AB; Smit AB
J Neurochem; 2019 Nov; 151(4):435-445. PubMed ID: 30289976
[TBL] [Abstract][Full Text] [Related]
2. Applications of iTRAQ and TMT Labeling Techniques to the Study of Neurodegenerative Diseases.
Li K; Chen Z; Zhang Y; Yang X
Curr Protein Pept Sci; 2020; 21(12):1202-1217. PubMed ID: 33143625
[TBL] [Abstract][Full Text] [Related]
3. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood.
Ge YJ; Ou YN; Deng YT; Wu BS; Yang L; Zhang YR; Chen SD; Huang YY; Dong Q; Tan L; Yu JT;
Biol Psychiatry; 2023 May; 93(9):770-779. PubMed ID: 36759259
[TBL] [Abstract][Full Text] [Related]
4. Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach.
Cartas-Cejudo P; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768771
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's and Parkinson's diseases: an environmental proteomic point of view.
Demartini DR; Schilling LP; da Costa JC; Carlini CR
J Proteomics; 2014 Jun; 104():24-36. PubMed ID: 24751585
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal Dysfunction at the Centre of Parkinson's Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
Wallings RL; Humble SW; Ward ME; Wade-Martins R
Trends Neurosci; 2019 Dec; 42(12):899-912. PubMed ID: 31704179
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in Neurodegenerative Diseases.
Jeromin A; Bowser R
Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
[TBL] [Abstract][Full Text] [Related]
8. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
[TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis.
Katzeff JS; Bright F; Phan K; Kril JJ; Ittner LM; Kassiou M; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS
Brain; 2022 Jun; 145(5):1598-1609. PubMed ID: 35202463
[TBL] [Abstract][Full Text] [Related]
10. Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis.
Puranik N; Yadav D; Yadav SK; Chavda VK; Jin JO
Curr Protein Pept Sci; 2020; 21(12):1174-1183. PubMed ID: 32392110
[TBL] [Abstract][Full Text] [Related]
11. Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation.
Katzeff JS; Bright F; Lo K; Kril JJ; Connolly A; Crossett B; Ittner LM; Kassiou M; Loy CT; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS
Sci Rep; 2020 Aug; 10(1):13741. PubMed ID: 32792518
[TBL] [Abstract][Full Text] [Related]
12. Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration.
Peng W; Minakaki G; Nguyen M; Krainc D
Neurotherapeutics; 2019 Jul; 16(3):611-634. PubMed ID: 31183763
[TBL] [Abstract][Full Text] [Related]
13. Biomarker discovery in neurodegenerative diseases: a proteomic approach.
Shi M; Caudle WM; Zhang J
Neurobiol Dis; 2009 Aug; 35(2):157-64. PubMed ID: 18938247
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for Managing Neurodegenerative Diseases.
Cheslow L; Snook AE; Waldman SA
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672416
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models.
González De Aguilar JL; René F; Dupuis L; Loeffler JP
Neuroendocrinology; 2003 Nov; 78(5):244-52. PubMed ID: 14657605
[TBL] [Abstract][Full Text] [Related]
17. Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration.
Noori A; Mezlini AM; Hyman BT; Serrano-Pozo A; Das S
Neurobiol Dis; 2021 Feb; 149():105225. PubMed ID: 33347974
[TBL] [Abstract][Full Text] [Related]
18. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
[TBL] [Abstract][Full Text] [Related]
19. Neuroproteomics tools in clinical practice.
Shevchenko G; Konzer A; Musunuri S; Bergquist J
Biochim Biophys Acta; 2015 Jul; 1854(7):705-17. PubMed ID: 25680928
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics of Alzheimer's disease and frontotemporal dementia.
Veerappan CS; Sleiman S; Coppola G
Neurotherapeutics; 2013 Oct; 10(4):709-21. PubMed ID: 24150812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
